ArticleCommunications biology2024
Contribution of host species and pathogen clade to snake fungal disease hotspots in Europe.
Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 10 citations in OpenAlex.
- Ophidiomycosis Prevalence and Disease Ecology in a Natrix tessellata (Laurenti, 1768) Population From Northern Italy.Journal of experimental zoology. Part A, Ecological and integrative physiology · 2026Article
- Preliminary Screening forMicroorganisms · 2026Article
- Health assessment and multipathogen surveillance of free-ranging snakes in the southeastern United States.Frontiers in veterinary science · 2026Article
- Oo-No: Ophidiomyces ophidiicola-bacterial interactions and the role of skin lipids in development of ophidiomycosis.PLoS pathogens · 2026Article
- Mortality Event in Rainbow Snakes Linked to Snake Fungal Disease, United States.Emerging infectious diseases · 2025Article
- Microorganisms in wild European reptiles: bridging gaps in neglected conditions to inform disease ecology research.International journal for parasitology. Parasites and wildlife · 2025Review
- Effects of snake fungal disease (ophidiomycosis) on the skin microbiome across two major experimental scales.Conservation biology : the journal of the Society for Conservation Biology · 2025Article
- Nationwide Screening Unveils EndemicJournal of fungi (Basel, Switzerland) · 2025Article
- Retrospective Detection ofMicroorganisms · 2024Article
- Paranannizziopsis spp. Infection in Wild Vipers, Europe.Emerging infectious diseases · 2024Article
- Snake Fungal Disease in Free-Ranging Northern Pine Snakes (Journal of fungi (Basel, Switzerland) · 2024Article
Corrections and comments
- Erratum issued
Authors and funding
19 authors at 14 institutions in 10 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infectious diseases are influenced by interactions between host and pathogen, and the number of infected hosts is rarely homogenous across the landscape. Areas with elevated pathogen prevalence can maintain a high force of infection and may indicate areas with disease impacts on host populations. However, isolating the ecological processes that result in increases in infection prevalence and intensity remains a challenge. Here we elucidate the contribution of pathogen clade and host species in disease hotspots caused by Ophidiomyces ophidiicola, the pathogen responsible for snake fungal disease, in 21 species of snakes infected with multiple pathogen strains across 10 countries in Europe. We found isolated areas of disease hotspots in a landscape where infections were otherwise low. O. ophidiicola clade had important effects on transmission, and areas with multiple pathogen clades had higher host infection prevalence. Snake species further influenced infection, with most positive detections coming from species within the Natrix genus. Our results suggest that both host and pathogen identity are essential components contributing to increased pathogen prevalence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.